IBEC in the Media Archives - Institute for Bioengineering of Catalonia (IBEC)

Pere Roca-Cusachs elected new EMBO member

July 7, 2020 August 4, 2020

Pere Roca-Cusachs, principal investigator at IBEC, is the only Catalan chosen this year to join the prestigious European Molecular Biology Organization (EMBO).

Elisabeth Engel at Santander Pioneros: it’s time to support science

July 2, 2020 July 8, 2020

Three protagonists of the medical research field in Spain debated in a new edition of the “Pioneros Santander” forum, organized virtually by El País Retina. Elisabeth Engel, group leader of Biomaterials for regenerative therapies at IBEC, Rocío Arroyo, CEO of Amadix and Eduardo Jorgensen, of Medicsen, also CEO, agreed to celebrate the greatest interest in their work area, the intersection between science, technology and health, but at the same time they were cautious: there are no shortcuts in research, neither before Covid-19 nor after.

Nuria Montserrat talks in the media about Mini-kidneys, diabetes and coronavirus

June 20, 2020 July 8, 2020

Researchers at the Institute of Bioengineering of Catalonia (IBEC) led by Núria Montserrat have found in vitro that diabetes is a disease that accelerates Covid-19. In the lab, they have also created mini-hearts to study the heart problems caused by Covid-19.

A “faster and safer” therapy against tuberculosis

June 19, 2020 June 30, 2020

A team of international scientists led by the Institute for Bioengineering of Catalonia (IBEC) has developed a “faster, more effective and safer” therapy to eliminate infections of intracellular bacteria that cause diseases such as tuberculosis. Scientists participating in the study include Group Leader Giuseppe Battaglia and the researcher Loris Rizzello of IBEC.

Josep Samitier talks about how the redistribution of funds will affect research

June 17, 2020 June 18, 2020

Josep Samitier, director of the Institute for Bioengineering of Catalonia and president of the Catalan Association of Research Entities (ACER), assesses how science and technology can be affected by the fact that 53 million euros, that had to be invested in research, have been redirected to the healthcare sector, due to the coronavirus outbreak.

Samuel Sánchez elected new member of the Young Academy of Spain

June 3, 2020 August 4, 2020

An international committee has elected Samuel Sánchez, the European referent in nanomotors, as one of the new 13 researchers, among 185 candidates, who will be a member of the Young Academy of Spain.

Magnet Alliance on the radio

May 28, 2020 June 17, 2020

Àngels Suarez, teacher at Gayarre school, explained the alliance between IBEC and the Gayarre School within the frame of the project “Magnet, alliances for educational success”. This initiative unites educational centres that have an unbalanced social composition with an institution of excellence for 4 years. This union will allow the educational centre to develop an innovative project that will become a reference project in its territory. During her intervention, she also shared with the audience a virtual experiment, easy to perform in our homes, to explain the density.

Núria Montserrat in a feature article at the ERC’s covid-19 section: Stopping coronavirus at the gate

May 4, 2020 May 20, 2020

ERC grantee Nuria Montserrat and her team create tiny kidneys which are proving to be key in the search for coronavirus drugs. The researcher is working with other international researchers and found that a trial drug could block early stages of COVID19. The ERC has created a section which is updated with the latest news about the ERC-funded research in coronavirus.

The research with organoids against COVID19 reaches the international press

April 28, 2020 June 4, 2020

One of the most prestigious German newspapers, the Süddeutsche Zeitung echoes the work of Núria Montserrat and her international partners who are investigating with organoids a drug that blocks the entrance door of Covid19.

Mini-kidneys to test a drug to stop Covid-19

April 6, 2020 June 4, 2020

Nuria Montserrat, principal investigator of the “Pluripotency for organ regeneration” and her group have participated in an international study to find a treatment to stop the virus from continuing infecting other cells, preventing the virus from replicating.